Mugglehead speaks with MediPharm president Keith Strachan about how the cannabis extraction pioneer is gearing up for the launch of Cannabis 2.0 products in Canada.
Aurora Cannabis nets $86.5 million in cash by selling its remaining stake in The Green Organic Dutchman as both companies strategies evolve.
Vivien Azer at Cowen & Co. cut her price target on the Canadian pot producer to $60 from $150, but she believes the stock's recent collapse presents a buying opportunity.
The Denver-based company recorded a 35% jump in revenue from last quarter as it saw increased demand for its distinct cannabis brand in California and Michigan.
The Ottawa-based pot firm saw its revenues surge from its California operations, and it expects further growth once its acquisition by Chicago-based Cresco Labs is approved and closes.
Shares of The Alkaline Water Co. surged 24 per cent after it said it is teaming up with the first-ever legal CBD company in the U.S. to expand its CBD product portfolio.
Despite Curaleaf reporting wider losses and lower-than-expected revenues in the second-quarter, investors remained upbeat on its more than US$1-billion revenue guidance for 2020.
The Vancouver-based pot producer inked a deal with a "Canadian beverage technology company" to ready itself for the coming next-phase infused product launch in Canada later this year.
The Toronto-based pot company is the latest to make its foray into the U.S. by acquiring Quill, a multi-state vape technology brand known for its health-focused disposable vape pens.
Analysts have been bullish on the U.K. drugmaker raising estimates and price targets after its second-quarter sales easily surpassed expectations.
The California-based pot retailer will provide a same-day home delivery service and offer more than 400 products across the state, which is considered the largest legal cannabis market.
Despite 40 per cent of its market value being wiped out since March, the Edmonton-based company has bold plans to dominate the global hemp CBD market moving forward.
Shares of Canopy sunk to their lowest level this year, as the Ontario-based cannabis giant saw pot sales decline in Canada for the third straight quarter while losses continue to pile.
Acreage shares fell 10 per cent after it posted a second-quarter loss of US$33.9 million, but the American pot firm said it plans to open up pot shops under Canopy's brands across the U.S.
Shares of the B.C.-based pot producer tumbled after it posted a wider-than-expected loss for the second quarter and despite revenues nearly doubling from the last quarter.
While investors brace for cannabis companies to post quarterly losses, the Barrie, Ont.-based pot extractor reported a second-quarter profit ahead of the launch of Cannabis 2.0 products.
In previous years greenhouse operator Village Farms mainly grew tomatoes, but now the Vancouver-based company cannabis joint venture is helping it turn bigger quarterly profits.
As the cannabis industry reaches the heart of earnings season, investors are looking for profits and weren't impressed with Cronos CEO's second-half spending projections in its Q2 report.
Problems continue to mount for CannTrust after it revealed Health Canada found several new regulatory breaches at the cannabis company's Vaughan, Ont. manufacturing facility.
Shares in CannTrust swung wildly on Friday after the embattled pot producer revealed its outside auditor was withdrawing its year-end and first-quarter reports.
The Columbus-based CBD retailer will have 105 of its Seventh Sense shops open in malls across the U.S. by Aug. 8.
Shares of Aurora rose after the Edmonton-based pot company estimated its fourth quarter production available for sale could reach 30,000 kilograms, up 5,000 kilograms from its previous guidance report.
America's No. 1 selling iced tea brand is going to pot by inking a licensing deal with Colorado-based Dixie Brands to make and sell cannabis-infused gummies, drinks and vape pens.
The Phoenix-based company owns, operates or manages six cultivation and production facilities and 11 retail stores across eight states and began trading on the Canadian Securities Exchange on Aug. 6.
While embattled cannabis producer CannTrust awaits its fate with Health Canada for its regulatory breach, Aphria told Bloomberg it might consider buying the troubled company's assets.
The Toronto-based company makes it first deal to get inside the U.S. CBD market by acquiring Redwood Holding Group, owner of popular CBD brand Lord Jones.
The troubled Canadian pot company hired Greenhill & Co Inc. to help it conduct a "review of strategic alternatives," including finding a buyer, while it awaits federal enforcement action.
The Ontario-based pot firm posted a profit of $15.8 million in its fourth quarter on a net revenue of $128.6 million fueled by a jump in Canadian recreational cannabis sales.
The Friendly Bear's short seller report alleges Hexo ran aggressive advertisements on Snapchat, but so far shares of the Quebec-based cannabis firm remain unharmed.
The Florida-based company said it is opening its 30th location in the Sunshine State and continues to build on its success in the state's medical cannabis market.
But Canada's largest pot retailer posted a net loss of $4.8 million in its third quarter as expenses continue to mount for the company that now has 34 stores open.
The latest distribution deal with Kroger gives the Colorado-based company a total of five tie-ups with major U.S. retailers to ship its hemp CBD topical products into a total of 8,000 U.S. locations.
The British-based tobacco firm and the Canadian pot company say the sizeable deal will help both execute their global cannabis vape plans.
The Globe and Mail and BNN Bloomberg released troubling reports this week alleging CannTrust CEO and company executives were made aware of illegal growing in November.
The Quebec-based retail giant's $26 million investment will help Fire & Flower expand its presence of 23 cannabis stores in Alberta, Saskatchewan and Ontario.
The Calgary-based company announced terms and aims to raise US$130 million with its initial public offering on the Nasdaq.
The FDA issued a warning letter to the largest cannabis company based in the U.S. for illegally selling and providing unproven claims online for its CBD products.
Illinois-based Cresco Labs, one of America's larger multi-state cannabis operators, wants to sell medical and recreational pot next to the iconic stadium that hosts the Chicago Cubs.
The Massachusetts-based company said the deal with Grassroots will make it the largest marijuana company in the world and will bring its products into 19 states, up from 12.
The Vancouver-based pot company is the first to have its licences revoked from the federal regulator for allegedly selling cannabis products to the black market last year.








































